People: Fresenius Medical Care AG & Co KGaA (FMEG.DE)

FMEG.DE on Xetra

52.43EUR
11:35am EDT
Price Change (% chg)

€0.63 (+1.22%)
Prev Close
€52.95
Open
€52.10
Day's High
€52.46
Day's Low
€51.60
Volume
428,056
Avg. Vol
847,736
52-wk High
€60.27
52-wk Low
€47.79

Search Stocks

Summary

Name Age Since Current Position

Gerd Krick

 1998 Chairman of the Supervisory Board

Rice Powell

 2013 Chairman of the Management Board, Chief Executive Officer

Ben Lipps

 2013 Honorary Chairman

Dieter Schenk

 1996 Vice Chairman of the Supervisory Board

Michael Brosnan

 2010 Chief Financial Officer, Member of the Management Board

Oliver Maier

 Senior Vice President of Investor Relations

Rainer Runte

 2005 Chief Compliance Officer, General Counsel, Member of the Management Board

Roberto Fuste

 1999 Member of the Management Board

Emanuele Gatti

 1997 Member of the Management Board

Ronald Kuerbitz

 2012 Member of the Management Board

Kent Wanzek

 2010 Member of the Management Board, Global Products Manufacturing Operations

Rolf Classon

 68 2011 Member of the Supervisory Board

Bernd Fahrholz

 1998 Member of the Supervisory Board

William Johnston

 2006 Member of the Supervisory Board

Walter Weisman

 1996 Member of the Supervisory Board
» Insider Trading

Biographies

Name Description

Gerd Krick

 Dr. Gerd Krick has been Chairman of the Supervisory Board at Fresenius Medical Care AG & Co KGaA since January 1, 1998. Additionally, Dr. Krick acts as Member of the Audit and Corporate Governance Committee, as well as Chairman of the Nominating Committee at the Company. He was Chairman of the Fresenius AG Management Board from 1992 to May 2003 at which time he became Chairman of the Supervisory Board. Prior to 1992, he was a Director of the Medical Systems Division of Fresenius AG and Deputy Chairman of the Fresenius AG Management Board. From September 1996 until December 1997, Dr. Krick was Chairman of the Management Board of Fresenius Medical Care. Dr. Krick was Member of the Advisory Board of HDI V.a.G until December 31, 2008, and Member of the Supervisory Board of Allianz Private Kankenversicherungs-AG until April 16, 2008. He acted as Chairman of the Supervisory Board of Fresenius SE until January 28, 2011. He is Chairman of the Supervisory Board of VAMED AG, Member of the Supervisory Board at Fresenius Medical Care Management AG. He has acted as Member of the Supervisory Board at Fresenius Management SE since March 11, 2010 and since May 12, 2010 as its Chairman.

Rice Powell

 Mr. Rice Powell has been appointed Chief Executive Officer and Chairman of the Management Board at Fresenius Medical Care AG & Co KGaA effective January 1, 2013. Prior to that, he served as Deputy Chairman of the Management Board at the Company and Chief Executive Officer of Fresenius Medical Care North America from January 1, 2010. Previously he acted as Member of the Management Board of Fresenius Medical Care AG & Co. KGaA, CEO of Renal Therapy Group of Fresenius Medical Care in North America. He has been representative of Fresenius Medical Care Management AG, general partner of the Company. He joined Fresenius Medical Care in 1997 and was appointed co-CEO and Member of the Management Board of Fresenius Medical Care North America in January 2004. Mr. Powell has experience in the healthcare industry. From 1978 to 1996 he held various positions within Baxter International Inc, Biogen Inc, and Ergo Sciences Inc, the United States, among others.

Ben Lipps

 Dr. Ben J. Lipps has been appointed Honorary Chairman of Fresenius Medical Care AG & Co KGaA effective January 1, 2013. After earning his Master and Doctoral degrees at the Massachusetts Institute of Technology in Chemical Engineering, Dr. Lipps led the research team that developed the first commercial Hollow Fiber Artificial Kidney at the end of the 1960s at DOW Chemical. Dr. Lipps has held the position of Chairman of the Management Board of Fresenius Medical Care Holdings Inc., USA and Member of the Management Board of Fresenius Management SE. He has also acted as Member of the Board of Vifor Fresenius Medical Care Renal Pharma Ltd.

Dieter Schenk

 Dr. Dieter Schenk has been Vice Chairman of the Supervisory Board of Fresenius Medical Care AG & Co KGaA since 1996. He is Member of the Nominating Committee at the Company. He is an attorney and tax advisor and has been a partner in the law firm of Noerr Stiefenhofer Lutz since 1986. Dr. Schenk occupied the position of Vice Chairman of the Supervisory Board at Fresenius SE until January 28, 2011. He acts as Vice Chairman of the Supervisory Board at Fresenius Medical Care Management AG and Greiffenberger AG. He is Chairman of the Supervisory Board of TOPTICA Photonics AG, as well as Gabor Shoes AG. In addition, he has held the position of Fresenius Management SE since March 11, 2011, and since May 12, 2010 the position of Deputy Chairman of its Supervisory Board. Dr. Schenk also acts as Member of the Board of Directors of Else-Kroener-Fresenius-Striftung.

Michael Brosnan

 Mr. Michael Brosnan has been Chief Financial Officer and Member of the Management Board at Fresenius Medical Care AG & Co KGaA since January 1, 2010. For the past seven years, he has served as Chief Financial Officer and Member of the Board of Directors of Fresenius Medical Care North America. Mr. Brosnan joined the Company in 1998 as Vice President of Finance and Administration for Spectra Renal Management, the Company’s laboratory services organization. Since then, he has held several executive positions in North America. Prior to joining Fresenius Medical Care, Mr. Brosnan held senior financial positions at Polaroid Corporation and was an Audit Partner at KPMG.

Oliver Maier

Rainer Runte

 Dr. Rainer Runte has been Chief Compliance Officer, General Counsel and Member of the Management Board of Fresenius Medical Care AG & Co KGaA since December 21, 2005. He is a representative of Fresenius Medical Care Management AG, the general partner of the Company. Previously he served as scientific assistant to the law department of the Johann Wolfgang Goethe University in Frankfurt and as an attorney in a law firm specialized in economic law. Dr. Runte took the position as Senior Vice President for Law of Fresenius Medical Care in 1997 and was appointed as Deputy Member of the Management Board in 2002. Dr. Runte acts as Member of the Board of Directors of Vifor Fresenius Medical Care Renal Pharma Ltd., as well as Member of the Supervisory Board of Fresenius Medical Care Groupe France S.A.S, Fresenius Medical Care SGPS, S.A., Fresenius Medical Care Japan, K.K., and Fresenius-Kawasumi Co., Ltd.

Roberto Fuste

 Mr. Roberto Fuste has been Member of the Management Board of Fresenius Medical Care AG & Co KGaA since January 1, 1999. After finishing his studies in economic sciences at the University of Valencia, he founded the company Nephrocontrol SA in 1983. In 1991, Nephrocontrol was acquired by the Fresenius Group, where Mr. Fuste has worked since. Before being appointed to the Management Board of Fresenius Medical Care in 1999, Mr. Fuste held several senior positions within the company in the Latin America and the Asia-Pacific region.

Emanuele Gatti

 Dr. Emanuele Gatti has been Member of the Management Board at Fresenius Medical Care AG & Co KGaA since May 1997. After completing his studies in bioengineering, Dr. Gatti lectured at several biomedical institutions in Milan, Italy. He continues to be involved in comprehensive research and development activities focusing on dialysis and blood purification, biomedical signal analysis, medical device safety and health care economics. Dr. Gatti has been with the Company since 1989. Before being appointed to the Management Board in 1997, he was responsible for the dialysis business in Southern Europe. At present he is Visiting Professor and Chairman of the University Board at the Danube University in Krems, Austria. He is Chairman of the Management Board of Fresenius Medical Care Espana, as well as Member of the Management Board of National Medical Care of Spain S.A. He also holds the position of Deputy Chairman of the Supervisory Board of Fresenius Medical Care Groupe France S.A.S.

Ronald Kuerbitz

 Mr. Ronald Kuerbitz has been appointed Member of the Management Board of Fresenius Medical Care AG & Co KGaA since January 1, 2012. He joined Fresenius Medical Care in 1997 to lead its corporate development function and was later named as Fresenius Medical Care North America's General Counsel and Chief Administrative Officer. Mr. Kuerbitz has 20 years of experience in the health care field, having held positions in law, compliance, business development, government affairs and operations. Since 2011 Mr. Kuerbitz has served as Chairman of Kidney Care Partners in Washington D.C., a coalition of patient advocates, dialysis doctors, care providers and device and pharmaceutical manufacturers working together to improve the quality of care for individuals with chronic kidney disease. Mr. Kuerbitz is a graduate of Albion College and received his juris doctor degree from the Yale Law School.

Kent Wanzek

 Mr. Kent Wanzek has been Member of the Management Board, Global Products Manufacturing Operations at Fresenius Medical Care AG & Co KGaA since January 1, 2010. He has been the President for Operations of the Renal Therapies Group at Fresenius Medical Care North America since 2006. Prior to joining the Company in 2003, Mr. Wanzek had several senior executive positions including Philips Medical Systems and Baxter Healthcare Corporation.

Rolf Classon

 Mr. Rolf A. Classon has been Member of the Supervisory Board at Fresenius Medical Care AG & Co KGaA since May 11, 2011. He is Chairman of the Board of Directors of Hill-Rom Holdings, Inc. (previously Hillenbrand Industries, Inc.) He is also Member of the Supervisory Board at Fresenius Medical Care Management AG since July 7, 2011. Moreover, he serves as Chairman of the Board of Directors at Auxilium Pharmaceuticals, Inc. and at Tecan Group Ltd.

Bernd Fahrholz

 Prof. Dr. Bernd Fahrholz has been Member of the Supervisory Board of Fresenius Medical Care AG & Co KGaA since 1998. Additonally, he acts as Member of the Audit and Corporate Governance Committee of the Company. He serves as Chairman of the Supervisory Board of SMARTRAC N.V. He is an attorney and has been a partner in the law firm of Noerr Stiefenhofer Lutz since 2004. Prof. Dr. Fahrholz was Member of the Management Board of Dresdner Bank AG from 1998 and was Chairman from April 2000 until he resigned in March of 2003. He also served as Deputy Chairman of the Management Board of Allianz AG and Chairman of the Supervisory Board of Advance Holding AG until March 25, 2003. Prof. Dr. Fahrholz served on the Supervisory Board of BMW AG until May 13, 2004 and Heidelberg Cement AG until May 6, 2004.

William Johnston

 Dr. William P. Johnston has been Member of the Supervisory Board at Fresenius Medical Care AG & Co KGaA since May 9, 2006. Additionally, he acts as Member of the Audit and Corporate Governance Committee at the Company. Dr. Johnston is former Chairman of the Board of Directors of Renal Care Group, Inc. He is also a Member of the Supervisory Board of Fresenius Medical Care Management AG. In February 2008, he was appointed as Member of the Board of Directors of HCA-Manor Care, Inc. He also acts as Member of the Board of Directors of The Hartford Mutual Funds, Inc., LifeCare Holdings, Inc., Georgia O'Keeffe Museum. He acted as Member of the Board of Directors of Multiplan Inc. until August 31, 2010.

Walter Weisman

 Dr. Walter L. Weisman has been Member of the Supervisory Board at Fresenius Medical Care AG & Co KGaA since 1996. Additionally, he acts as Chairman of the Audit and Corporate Governance Committee, as well as Member of the Nominating Committee of the Company. He is a private investor and a former Chairman and Chief Executive Officer of American Medical International, Inc. Dr. Weisman is Member of the Management Board of Occidental Petroleum Corporation. He also acts as Member of the Supervisory Board of Fresenius Medical Care Management AG. He is Deputy Chairman of the Board of Trustees for the California Institute of Technology, a trustee of the Board of Trustees of the Los Angeles County Museum of Art, Chairman of the Board of Trustees of the Sundance Institute. Dr. Weisman was Vice Chairman and Lead Director of Maguire Properties, Inc. until September 1, 2008 and was Vice Chairman of the Board of Trustees of the Samuel H. Kess Foundatuon until 1, 2008.

Basic Compensation

Name Fiscal Year Total

Gerd Krick

 120,000

Rice Powell

 3,374,000

Ben Lipps

 4,862,000

Dieter Schenk

 43,000

Michael Brosnan

 2,713,000

Oliver Maier

 --

Rainer Runte

 1,998,000

Roberto Fuste

 1,493,000

Emanuele Gatti

 3,070,000

Ronald Kuerbitz

 --

Kent Wanzek

 1,799,000

Rolf Classon

 25,000

Bernd Fahrholz

 95,000

William Johnston

 62,000

Walter Weisman

 75,000
As Of 30 Dec 2012

Insider Trading

» Full list on Insider Trading
Search Stocks